Draxxin Kp 100 mg (Tulathromycin SOLUTION) 100 MG

DRAXXIN KP 100 MG is a subcutaneous solution containing tulathromycin, used for treating bacterial infections in animals. This broad-spectrum antibiotic is designed for veterinary use, offering targeted relief for various infections.

Strength

100 MG

Manufacturer / TM Owner

ZOETIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

DRAXXIN KP 100 MG is primarily used for treating bacterial infections in animals. It is effective against a range of bacterial strains, making it a versatile option for veterinary practitioners. This solution is administered subcutaneously, providing a convenient method for delivering the antibiotic directly to the site of infection.

Side Effects

DRAXXIN KP 100 MG may cause mild irritation at the injection site. Some animals might experience temporary discomfort or swelling. These effects are generally short-lived and should subside as the body adjusts to the medication.

Precautions & Warnings

Always follow the instructions provided by your veterinarian when administering DRAXXIN KP 100 MG. Ensure proper hygiene and sterilization of the injection site to prevent further infection. Monitor the animal for any adverse reactions and consult your veterinarian if concerns arise.

Avoid Interactions

DRAXXIN KP 100 MG may interact with other medications, particularly those metabolized by the liver. It is important to inform your veterinarian about any other medications or supplements your animal is taking to avoid potential interactions. Always consult with a healthcare professional before combining treatments.

Frequently Asked Questions

DRAXXIN KP 100 MG is used for treating bacterial infections in animals, offering broad-spectrum coverage against various bacterial strains.

DRAXXIN KP 100 MG is administered subcutaneously, meaning it is injected under the skin for direct absorption.

Common side effects may include mild irritation or swelling at the injection site, which typically subsides quickly.

DRAXXIN KP 100 MG may interact with other medications, so it is important to consult your veterinarian before combining treatments.

DRAXXIN KP 100 MG is designed for veterinary use, but its safety can vary based on the specific animal and its health condition. Always consult your veterinarian for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.